GetTopicDetailResponse(id=7e734454e66, topicName=奧拉帕尼, introduction=奧拉帕尼, content=null, image=null, comments=1, allHits=1964, url=https://h5.medsci.cn/topic?id=44547, type=1, isShow=1, status=1, isAdmin=null, adminId=1, adminEncryptionId=1eae1, adminName=小M, createdBy=null, createdName=, createdAvatar=, createdTime=Fri May 29 21:19:53 CST 2020, time=2020-05-29, bannerImg=https://img.medsci.cn/202167/1623032167418_5160405.png, bannerImgH5=https://img.medsci.cn/202167/1623032167418_5160405.png, likes=0, followStatus=false, moduleDTOList=null, tagId=12414, tagList=[TagDto(tagId=12414, tagName=奧拉帕尼)], ipAttribution=, topicAdmin=1, lengthMark=0)
[GetTopicListResponse(id=2210226, encodeId=1bc32210226f3, content=<a href='/topic/show?id=33771982175' target=_blank style='color:#2F92EE;'>#三陰性乳腺癌#</a> <a href='/topic/show?id=7e734454e66' target=_blank style='color:#2F92EE;'>#奧拉帕尼#</a>, objectTitle=Adv Sci：復旦大學張立行/柳素玲等發(fā)現(xiàn)促進三陰性乳腺癌腫瘤進展和奧拉帕尼耐藥的新機制, objectType=article, longId=830213, objectId=26f883021323, topicUrl=null, isHasObj=0, objectCover=https://img.medsci.cn/20240616/1718549483980_5579292.jpg, objectUrl=/article/show_article.do?id=26f883021323, replyNumber=0, likeNumber=161, createdTime=2024-06-16, rootId=0, userName=梅斯管理員, userId=cade5395722, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=上海, moduleDTOList=[ModuleDTO(moduleId=26f883021323, moduleTitle=Adv Sci：復旦大學張立行/柳素玲等發(fā)現(xiàn)促進三陰性乳腺癌腫瘤進展和奧拉帕尼耐藥的新機制, moduleType=article, hrefUrl=http://ermita.cn/article/show_article.do?id=26f883021323)], followStatus=false, userIsMember=false, type=null, lengthMark=0), GetTopicListResponse(id=2190738, encodeId=a4e52190e3842, content=<a href='/topic/show?id=330410333110' target=_blank style='color:#2F92EE;'>#黑色素瘤#</a> <a href='/topic/show?id=7e734454e66' target=_blank style='color:#2F92EE;'>#奧拉帕尼#</a>, objectTitle=論文解讀｜Zeng H/Zhang W/?Zhang Y教授團隊揭示奧拉帕尼在治療BRCA1突變型肢端型黑色素瘤方面的重大進展, objectType=article, longId=815485, objectId=04aa81548553, topicUrl=null, isHasObj=0, objectCover=https://img.medsci.cn/Random/patient-meeting-a-doctor-PAYSRMZ.jpg, objectUrl=/article/show_article.do?id=04aa81548553, replyNumber=0, likeNumber=109, createdTime=2024-03-03, rootId=0, userName=梅斯管理員, userId=cade5395722, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=上海, moduleDTOList=[ModuleDTO(moduleId=04aa81548553, moduleTitle=論文解讀｜Zeng H/Zhang W/?Zhang Y教授團隊揭示奧拉帕尼在治療BRCA1突變型肢端型黑色素瘤方面的重大進展, moduleType=article, hrefUrl=http://ermita.cn/article/show_article.do?id=04aa81548553)], followStatus=false, userIsMember=false, type=null, lengthMark=0), GetTopicListResponse(id=895340, encodeId=cfb989534073, content=<a href='/topic/show?id=7e734454e66' target=_blank style='color:#2F92EE;'>#奧拉帕尼#</a>治療轉移性去勢耐藥性<a href='/topic/show?id=c8ee32526f3' target=_blank style='color:#2F92EE;'>#前列腺癌#</a>, objectTitle=NEJM：奧拉帕尼治療轉移性去勢耐藥性前列腺癌, objectType=article, longId=194921, objectId=7e4c194921ab, topicUrl=null, isHasObj=0, objectCover=https://img.medsci.cn/2020528/1590663945198_2051781.jpg, objectUrl=/article/show_article.do?id=7e4c194921ab, replyNumber=0, likeNumber=251, createdTime=2020-10-29, rootId=0, userName=lovetcm, userId=7a3710, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=7e4c194921ab, moduleTitle=NEJM：奧拉帕尼治療轉移性去勢耐藥性前列腺癌, moduleType=article, hrefUrl=http://ermita.cn/article/show_article.do?id=7e4c194921ab)], followStatus=false, userIsMember=false, type=1, lengthMark=0)]
梅斯話題小助手
2020-05-29
